心痛泰通过降低Lp-PLA2、IL-6、hs-CRP、LOX-1水平减轻兔动脉粥样硬化炎症反应
DOI:
作者:
作者单位:

(湖南中医药大学第一附属医院 1.重症医学科,;3.老年病科,湖南省长沙市 410007;2.湖南中医药大学药学院,湖南省长沙市 410208)

作者简介:

易琼,博士,主治医师,主要从事心血管疾病的防治和重症医学的临床工作,E-mail为ikkyo@sina.com。

通讯作者:

基金项目:

湖南省中医药科研项目(201516)


Xin Tong-tai reduces inflammation of atherosclerosis by lowering the levels of Lp-PLA2, IL-6, hs-CRP and LOX-1 in rabbits
Author:
Affiliation:

1.Department of Intensive Care Unit, ;3.Department of Geriatrics, the First Affiliated Hospital, Hunan University of Chinese Medicine, Changsha, Hunan 410007, China;2.Pharmaceutical College, Hunan University of Chinese Medicine, Changsha, Hunan 410208, China)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 研究心痛泰对动脉粥样硬化兔血清脂蛋白相关磷脂酶A2(Lp-PLA2)、白细胞介素6(IL-6)以及主动脉组织高敏C反应蛋白(hs-CRP)和血凝素样氧化型低密度脂蛋白受体1(LOX-1)的影响。 方法 120只日本大耳白兔随机分为空白组、模型组、心痛泰低剂量组、中剂量组、高剂量组和瑞舒伐他汀组。采用前瞻性研究,造模的同时予以相应药物灌胃。60天后采血,测定血清Lp-PLA2和IL-6水平;免疫组织化学法检测胸主动脉hs-CRP和LOX-1含量。 结果 心痛泰低剂量组、中剂量组和高剂量组血清Lp-PLA2和IL-6水平比模型组低(P<0.01);与心痛泰低剂量组比较,心痛泰中剂量组和高剂量组、瑞舒伐他汀组血清Lp-PLA2和IL-6水平降低(P<0.01或P<0.05)。心痛泰中剂量组和高剂量组的hs-CRP和LOX-1表达水平比模型组低(P<0.01);与心痛泰低剂量组比较,心痛泰中剂量组和高剂量组、瑞舒伐他汀组的hs-CRP和LOX-1表达水平降低(P<0.05)。免疫组织化学染色显示,模型组主动脉内膜hs-CRP和LOX-1大量表达;与模型组比较,心痛泰低剂量组、中剂量组、高剂量组和瑞舒伐他汀组主动脉内膜hs-CRP和LOX-1表达减轻。 结论 心痛泰能降低动脉粥样硬化兔Lp-PLA2、IL-6、hs-CRP、LOX-1的水平,从而达到抗动脉粥样硬化炎症反应的作用。

    Abstract:

    Aim To study the effects of Xin Tong-tai (XTT) on serum lipoprotein-associated phospholipase A2 (Lp-PLA2) and interleukin 6 (IL-6), and aortic tissue high-sensitivity C-reactive protein (hs-CRP) and lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) in atherosclerotic rabbits. Methods A total of 120 healthy Japanese rabbits were randomly divided into control group, model group, low-dose XTT group, middle-dose XTT group, high-dose XTT group and rosuvastatin group. In this prospective study, the drug intervention groups were treated with the corresponding drugs at the same time. After 60 days, serum levels of Lp-PLA2 and IL-6 were measured; The contents of hs-CRP and LOX-1 in thoracic aorta were detected by immunohistochemistry method. Results The serum levels of Lp-PLA2 and IL-6 in low-dose XTT group, middle-dose XTT group and high-dose XTT group were lower than those in model group (P<0.01). Compared with low-dose XTT group, the serum levels of Lp-PLA2 and IL-6 were decreased in middle-dose XTT group, high-dose XTT group and rosuvastatin group (P<0.01 or P<0.05). The expression levels of hs-CRP and LOX-1 in middle-dose XTT group and high-dose XTT group were lower than those in model group (P<0.01). Compared with low-dose XTT group, the expression levels of hs-CRP and LOX-1 were decreased in middle-dose XTT group, high-dose XTT group and rosuvastatin group (P<0.05). Immunohistochemical staining showed that in model group, there was a large amount of hs-CRP and LOX-1 expression in aortic intima; Compared with model group, the expressions of hs-CRP and LOX-1 in the aorta were reduced in low-dose XTT group, middle-dose XTT group, high-dose XTT group and rosuvastatin group. Conclusion Xin Tong-tai can decrease the levels of Lp-PLA2, IL-6, hs-CRP and LOX-1 in atherosclerotic rabbits, so as to achieve the effect of reducing atherosclerosis inflammatory reaction.

    参考文献
    相似文献
    引证文献
引用本文

易琼,李雅,郭志华,乐金海,任欣,申思.心痛泰通过降低Lp-PLA2、IL-6、hs-CRP、LOX-1水平减轻兔动脉粥样硬化炎症反应[J].中国动脉硬化杂志,2017,25(8):796~799.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2016-06-02
  • 最后修改日期:2016-09-02
  • 录用日期:
  • 在线发布日期: 2017-07-12